Topics

Companies Related to "Scientists isolate individual cells that cause autoimmune disease" [Most Relevant Company Matches] RSS

16:21 EDT 3rd April 2020 | BioPortfolio

Here are the most relevant search results for "Scientists isolate individual cells that cause autoimmune disease" found in our extensive corporate database of over 50,000 company records.

Showing "Scientists isolate individual cells that cause autoimmune disease" Companies 1–25 of 5,300+

Relevant

INOVA Diagnostics, Inc

INOVA Diagnostics, Inc. was formed in 1987 by a group of scientists—drawn from the academic, clinical and industrial communities but united by one common interest... Autoimmune Disease Diagnostic Technology! INOVA's founders include research scientists who were directly involved in the early development of autoimmune disease serology as well as the people responsible for the first commercially a...


Memgen, LLC

Memgen is a clinical-stage biotechnology company developing immunotherapies to improve survival and quality of life of patients with cancer, autoimmune conditions and infectious diseases. Memgen’s patent-protected, re-engineered molecules, which are based on the tumor necrosis factor (TNF) superfamily of molecules, target specific receptors express...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the DEPArray™ platform which is based on the principle of dielectrophoresis to isolate and manipulate cells in suspension with a microelectronic array. The approach, patented by S...


Inova Diagnostics Inc

Our Mission Our single focus allows us to offer you unmatched quality, reliable consistency, and excellent value on the most comprehensive range of autoimmune testing reagents available anywhere. Our HistoryINOVA Diagnostics, Inc. was formed in 1987 by a group of scientists—drawn from the academic, clinical and industrial communities but united by one common interest... Autoimmune Disease Diagno...

4SC AG

4SC AG (ISIN DE0005753818) is a drug discovery and development company focused on autoimmune and cancer indications. Vidofludimus (4SC-101), a small molecule, is currently in a Phase IIb study in rheumatoid arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone d...

Tizona Therapeutics, Inc.

Tizona Therapeutics, Inc., is a privately held immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune disorders. A healthy immune system integrates information from pro-inflammatory and anti-inflammatory cells that regulate the immune system’s function. In cancer, tumor cells evade recognition by c...

Orchestra Therapeutics

Orchestra Therapeutics’ unique approach to controlling autoimmune diseases uses small peptide vaccines that appear to stimulate FOXP3+ Regulatory T-cells; a component of the immune system that is now recognized as being key in autoimmune pathogenesis. Rather than disrupting the function of the entire immune system, these therapeutic vaccines are designed to elicit a very specific response – ak...

AroTec Diagnostics Limited - reagents for autoimmune disease

AroTec Diagnostics is dedicated to the production and distribution of reagents to the autoimmune disease diagnostic industry.AroTec Diagnostics Limited reagents for autoimmune disease specialises in the production of reagents (purified autoantigens) for a

Repertoire Immune Medicines

Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportuni...

AutoImmune Inc

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered products to treat autoimmune and other cell-mediated inflammatory diseases. Each of these products is based on a common biological mechanism known as oral tolerance, which provides tissue specific immunosuppression to control disease without toxicity or significant side effects.

Keel Pharmaceuticals, Inc.

Keel Pharmaceuticals, Inc. is a private biopharmaceutical company that is developing new therapies to treat type 1 diabetes and other autoimmune diseases. Keels technology is based on the identification of specific protein processing and signalling defects present in the autoreactive white blood cells (lymphocytes) that cause autoimmune diseases. The identification of these defects has yielded a...

Scéil

Scéil, part of the Cellectis Group, delivers a service that allows individuals to freeze their adult stem cells and harness the future potential of regenerative medicine. Based on Nobel Prize-winning research, Scéil’s world-leading experts use cutting-edge techniques to take cells from a small sample of an individual’s skin and ‘reset’ t...

AllCells, LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, ...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem cell Research Institute in Korea. R-Japan’s proprietary technology is to isolate, multiply, and store adult mesenchymal stem cells with ensuring genetic integrity. R-Japan currently ...

Gossamer Bio Inc.

Gossamer Bio is a San Diego-based biopharmaceutical company focused on discovering, developing, and commercializing immunology-based therapeutics in the autoimmune, allergy/inflammation, and immuno-oncology disease areas. Our goal is to improve the lives of patients suffering from disease. We aim to create a business that allows value creation and capture ...

OncoMab™ GmbH

OncoMab™ GmbH's business is the development of human antibodies for the treatment of cancer. The OncoMab™ way is unique because the antibodies are not developed in mice or by genetic engineering, but are isolated directly from cancer patients. The OncoMab™ antibodies are part of the innate natural immunity against malignant cells. This innate immune system functions as the first defence agai...

The Immune Response Corporation

The Immune Response Corporation (OTCBB: IMNR.OB) is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimula...

AllCells LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, ...

Circe Biomedical Incorporated

Circe Biomedical is committed to the development, production, and commercialization of novel bioartificial organs based on its proprietary mammalian cell and semi-permeable membrane technologies. These technologies enable the company to: Isolate, purify, and preserve primary mammalian cells Fabricate semipermeable, biocompatible membranes designed to regulate the passage of selected molecules D...

Myeloma Canada

Multiple myeloma, a cancer of the bone marrow, is an incurable but treatable disease. The cancer starts in plasma cells, which are produced in the bone marrow. In myeloma, abnormal plasma cells, called myeloma cells, grow uncontrollably, crowding out the normal blood cells in the bone. This can bring on symptoms such as fatigue, recurrent infections and se...

Diamyd Medical AB (publ)

The purpose of the GAD65-based diabetes therapy Diamyd(R) is to prevent, delay, or stop the autoimmune attack on beta cells in type 1 diabetes and other forms of autoimmune diabetes, thereby preserving the body's capacity to regulate blood sugar. This reduces the risk for both acute and long term diabetes complications significantly.

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...

Rheos Medicines

Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop novel therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer. Our approach targets the underlying intracellular metabolism of immune cells and has the potential to unlock a new frontier in drug discovery for immune-...

Acceptys, Inc.

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The Company's key strength is its ability to directly leverage the power of the human immune system, which has continually evolved with the specific purpose of preserving health. More specifically, Acceptys can capture thousands of antibodies from strategically targ...

NDRI

Human Tissues and Organs for Tomorrow's Scientific BreakthroughsTo serve scientists with customized biomaterials for use in studies to understand human disease. Human cells, tissues, and organs are required to investigate how human disease progresses and to develop new drugs and therapies for treatments and cures.Dedication to Highest QualityNDRI is dedicated to providing the highest quality human...


More From BioPortfolio on "Scientists isolate individual cells that cause autoimmune disease"

Quick Search

Corporate Database Quicklinks